Posts In: Pharma

Hyderabad’s Biological E: The dark horse in India’s vaccine race

December 9, 2020 Pharma

Biological E has forged multiple deals to co-develop and manufacture Covid-19 vaccines, and is prepared to take on the biggest in the business. It could...

Continue Reading

Aurobindo Pharma completes sale of Natrol LLC to New Mountain Capital

December 2, 2020 Pharma

Earlier, Aurobindo Pharma Managing Director N Govindarajan had said that proceeds from Natrol’s divestiture will be used to reduce debt and other new strategic initiatives....

Continue Reading

Indian Immunologicals to set up new unit in Telangana

December 2, 2020 Pharma

Hyderabad-based biologicals company, Indian Immunologicals Ltd (IIL), announced the ground-breaking of a new viral antigen manufacturing facility in Phase III of Genome Valley, Karkapatla, Ranga...

Continue Reading

PM Modi pushes refrigerated vaccine transport boxes tie up with Luxembourg company in Gujarat

December 2, 2020 Pharma

According to official sources based in Delhi and Ahmedabad, Luxembourg firm B Medical Systems is sending a high-level team to Gujarat next week to set...

Continue Reading

Virtual conference on “Supply Chain Challenges of COVID-19 Vaccines: Indian Imperative ”

November 18, 2020 Pharma

Click Here to Register

Continue Reading

Singapore startup develops 60-second COVID-19 breathalyzer test

November 18, 2020 Pharma

Singapore’s Breathonix has said a clinical trial of its COVID-19 breathalyzer test was able to achieve at least 90% accuracy after screening participants on-site for...

Continue Reading

Amit Srivastava joins Legacy Healthcare India as Board Member

November 18, 2020 Pharma

Srivastava will head Legacy Healthcare’s India operations and lead the company’s initiatives from the India office in Bengaluru, with a focus on research to explore...

Continue Reading

TS eyes on $50 bn revenues from life sciences by 2030

November 11, 2020 Pharma

Telangana is aiming to achieve $50 billion in cluster revenues (and $100 billion ecosystem valuation) by 2030, and believes that the sector would need to...

Continue Reading

Drugs and vaccines may not swiftly end pandemic, says Merck & Co’s CEO

November 11, 2020 Pharma

Merck & Co’s CEO Kenneth Frazier has warned that the drugs and vaccines in the pipeline to combat COVID-19 may not be enough to swiftly...

Continue Reading